NewslettersPulmonary Cell NewsUncategorizedTherapeutic Targeting of BAP1/ASXL3 Sub-complex in ASCL1-Dependent Small Cell Lung CancerBy Justin.choi - February 24, 2022086Researchers investigated the function of the oncogenic BAP1/ASXL3/BRD4 epigenetic axis in small cell lung cancer by developing a next-generation BAP1 inhibitor.[Oncogene] 6445212 AAAAAAAA items 1 apa 0 default asc 1 172195 https://www.stemcellsciencenews.com/wp-content/plugins/zotpress/Full Article